Chronic treatment with agents that stabilize cytosolic IkappaB-alpha enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch.

Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med (Berl) (2008) 1.86

Increased resting intracellular calcium modulates NF-κB-dependent inducible nitric-oxide synthase gene expression in dystrophic mdx skeletal myotubes. J Biol Chem (2012) 1.13

Peptide-based inhibition of NF-κB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy. Mol Med (2011) 1.09

Inhibitory control over Ca(2+) sparks via mechanosensitive channels is disrupted in dystrophin deficient muscle but restored by mini-dystrophin expression. PLoS One (2008) 1.08

Wasting mechanisms in muscular dystrophy. Int J Biochem Cell Biol (2013) 1.07

Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation. Neuromuscul Disord (2010) 1.01

Inhibition of the IKK/NF-κB pathway by AAV gene transfer improves muscle regeneration in older mdx mice. Gene Ther (2010) 1.00

Protein-DNA array-based identification of transcription factor activities differentially regulated in skeletal muscle of normal and dystrophin-deficient mdx mice. Mol Cell Biochem (2008) 0.93

Reduced resting potentials in dystrophic (mdx) muscle fibers are secondary to NF-κB-dependent negative modulation of ouabain sensitive Na+-K+ pump activity. J Neurol Sci (2011) 0.90

Therapeutic targeting of signaling pathways in muscular dystrophy. J Mol Med (Berl) (2009) 0.90

Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-kappaB pathway. J Neurol Sci (2010) 0.88

Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials. ILAR J (2014) 0.88

Soluble activin receptor type IIB increases forward pulling tension in the mdx mouse. Muscle Nerve (2011) 0.85

The influence of passive stretch and NF-κB inhibitors on the morphology of dystrophic muscle fibers. Anat Rec (Hoboken) (2010) 0.80

NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy. Skelet Muscle (2014) 0.78

Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice. Hum Mol Genet (2015) 0.77

The effect of specific IKKβ inhibitors on the cytosolic expression of IκB-α and the nuclear expression of p65 in dystrophic (MDX) muscle. Am J Transl Res (2015) 0.76

Decreased inward rectifier potassium current IK1 in dystrophin-deficient ventricular cardiomyocytes. Channels (Austin) (2016) 0.75

Minor withanolides of Physalis longifolia: structure and cytotoxicity. Chem Pharm Bull (Tokyo) (2012) 1.04

Increases in nuclear p65 activation in dystrophic skeletal muscle are secondary to increases in the cellular expression of p65 and are not solely produced by increases in IkappaB-alpha kinase activity. J Neurol Sci (2009) 0.92

Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor. J Lipid Res (2004) 0.89

Synthesis and Cytotoxicity of Semisynthetic Withalongolide A Analogues. ACS Med Chem Lett (2013) 0.83

Skeletal myogenesis in the zebrafish and its implications for muscle disease modelling. Results Probl Cell Differ (2015) 0.76